Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tsunoda

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 2, 2025
Management of obesity in liver transplant candidates and recipients: Rethinking the false dichotomy between pharmacotherapy and surgical interventionJessica P E Davis, Anesia Reticker, Hyosun Han, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2025
Establishing best practices for obesity and metabolic syndrome in liver transplantation: Insights from a modified Delphi-based controversies conferenceJessica P E Davis, Zachary Henry, Pratima Sharma, et al.
Clinical Transplantation|July 13, 2020
National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantationKimberly M Deininger, Shirley M Tsunoda, Jan D Hirsch, et al.
Journal of the American Society for Mass Spectrometry|September 30, 2018
Computational Removal of Undesired Mass Spectral Features Possessing Repeat Units via a Kendrick Mass FilterRicardo R da Silva, Fernando Vargas, Madeleine Ernst, et al.
Plos One|July 26, 2022
Non-invasive skin sampling detects systemically administered drugs in humansMorgan Panitchpakdi, Kelly C Weldon, Alan K Jarmusch, et al.
Analytical Chemistry|May 11, 2019
Initial Development toward Non-Invasive Drug Monitoring via Untargeted Mass Spectrometric Analysis of Human SkinAlan K Jarmusch, Emmanuel O Elijah, Fernando Vargas, et al.
Journal of Clinical Pharmacology|May 4, 2019
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy AdultsJincheng Yang, Mina Nikanjam, Edmund V Capparelli, et al.
Pharmacogenomics|November 23, 2019
Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantationKimberly M Deininger, Jacinda N Tran, Shirley M Tsunoda, et al.
Cancer Research|May 15, 1996
Dual recognition of a human cytotoxic T-cell clone for melanoma antigensH Kubo, J Abe, F Obata, et al.
Journal of Clinical Pharmacology|April 18, 2018
Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic ApproachJincheng Yang, Maulik Patel, Mina Nikanjam, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 2, 2025
Management of obesity in liver transplant candidates and recipients: Rethinking the false dichotomy between pharmacotherapy and surgical interventionJessica P E Davis, Anesia Reticker, Hyosun Han, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2025
Establishing best practices for obesity and metabolic syndrome in liver transplantation: Insights from a modified Delphi-based controversies conferenceJessica P E Davis, Zachary Henry, Pratima Sharma, et al.
Clinical Transplantation|July 13, 2020
National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantationKimberly M Deininger, Shirley M Tsunoda, Jan D Hirsch, et al.
Journal of the American Society for Mass Spectrometry|September 30, 2018
Computational Removal of Undesired Mass Spectral Features Possessing Repeat Units via a Kendrick Mass FilterRicardo R da Silva, Fernando Vargas, Madeleine Ernst, et al.
Plos One|July 26, 2022
Non-invasive skin sampling detects systemically administered drugs in humansMorgan Panitchpakdi, Kelly C Weldon, Alan K Jarmusch, et al.
Analytical Chemistry|May 11, 2019
Initial Development toward Non-Invasive Drug Monitoring via Untargeted Mass Spectrometric Analysis of Human SkinAlan K Jarmusch, Emmanuel O Elijah, Fernando Vargas, et al.
Journal of Clinical Pharmacology|May 4, 2019
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy AdultsJincheng Yang, Mina Nikanjam, Edmund V Capparelli, et al.
Pharmacogenomics|November 23, 2019
Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantationKimberly M Deininger, Jacinda N Tran, Shirley M Tsunoda, et al.
Cancer Research|May 15, 1996
Dual recognition of a human cytotoxic T-cell clone for melanoma antigensH Kubo, J Abe, F Obata, et al.
Journal of Clinical Pharmacology|April 18, 2018
Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic ApproachJincheng Yang, Maulik Patel, Mina Nikanjam, et al.
Pageof 18